NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)
International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

NCT06174727

RecruitingN/A

Sponsor: Montefiore Medical Center

Conditions: Intracranial Aneurysm

Countries: United States, Canada

This multicenter retrospective cohort study aims to evaluate and compare the technical performance, safety, and clinical outcomes of intracranial aneurysms treated with flow diverter stents and endosaccular flow disruptors.

Eligibility overview

Sex: ALL

Age: 18 Years to

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria
Inclusion Criteria:

* Consecutive adult patients (18 years of age or older)
* Underwent endovascular treatment with one of the following devices:

  a. Endoluminal Flow Diverter Stents: i. Pipeline Flex (Covidien, California, USA) ii. Pipeline Flex with Shield Technology (Covidien) iii. Surpass Streamline (Stryker Neurovascular, California, USA) iv. Surpass Evolve (Stryker) v. Silk flow diverter (Balt Extrusion, Montmorency, France) vi. Flow-Redirection Intraluminal Device (FRED; MicroVention) vii. Flow-Redirection Intraluminal Device X (FRED X; MicroVention) viii. p64 Flow Modulation Device (phenox GmbH) ix. Endovascular clip system (eCLIPs) (eCLIPsTM, eVasc Neurovascular, Vancouver, BC, Canada)

  b. Intrasaccular Flow Disruptors: i. Woven EndoBridge (WEB; MicroVention) ii. Luna/Artisse System (Medtronic) iii. Medina Embolic Device (Medtronic) iv. Contour Neurovascular System (Cerus Endovascular) v. Neqstent Coil Assisted Flow Diverter (Cerus Endovascular) vi. pCONus and pCANvas (phenox GmbH) vii. Nexus Aneurysm Embolization System (EndoStream Medical) viii. CITADEL™ Embolization Device (Balt, USA)
* Complete medical records and follow-up data available

Exclusion Criteria:

* Incomplete procedural or follow-up records
* Non-flow-diverter or non-flow-disruptor treatments (e.g., coiling-only cases)
* Aneurysms treated with investigational devices not listed within Inclusion Criteria
Locations (13)
  • Coral Gables, Florida, United States
  • Jacksonville, Florida, United States
  • Sarasota, Florida, United States
  • Burlington, Massachusetts, United States
  • Traverse City, Michigan, United States
  • Minneapolis, Minnesota, United States
  • New Brunswick, New Jersey, United States
  • Buffalo, New York, United States
  • The Bronx, New York, United States
  • Danville, Pennsylvania, United States
  • Kingwood, Texas, United States
  • Toronto, Ontario, Canada
  • Toronto, Ontario, Canada